Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols

  • Modou O. Kane
  • Nelly Etienne-Selloum
  • Soccoro V. F. Madeira
  • Mamadou Sarr
  • Allison Walter
  • Stéphanie Dal-Ros
  • Christa Schott
  • Thierry Chataigneau
  • Valérie B. Schini-KerthEmail author
Cardiovascular Physiology


Angiotensin II (Ang II)-induced hypertension is associated with vascular oxidative stress and an endothelial dysfunction. This study examined the role of reactive oxygen species (ROS) and endothelium-derived contracting factors in Ang II-induced endothelial dysfunction and whether these effects are prevented by red wine polyphenols (RWPs), a rich source of natural antioxidants. Rats were infused with Ang II for 14 days. RWPs were administered in the drinking water 1 week before and during the Ang II infusion. Arterial pressure was measured in conscious rats. Vascular reactivity was assessed in organ chambers and cyclooxygenase-1 (COX-1) and COX-2 expression by Western blot and immunofluorescence analyses. Ang II-induced hypertension was associated with blunted endothelium-dependent relaxations and induction of endothelium-dependent contractions in the presence of nitro-L-arginine in response to acetylcholine (Ach). These effects were not affected by the combination of membrane permeant analogs of superoxide dismutase and catalase but were abolished by the thromboxane A2 (TP) receptor antagonist GR32191B and the COX-2 inhibitor NS-398. The COX-1 inhibitor SC-560 also prevented contractile responses to Ach. Ang II increased the expression of COX-1 and COX-2 in the aortic wall. RWPs prevented Ang II-induced hypertension, endothelial dysfunction, and upregulation of COX-1 and COX-2. Thus, Ang II-induced endothelial dysfunction cannot be explained by an acute formation of ROS reducing the bioavailability of nitric oxide but rather by COX-dependent formation of contracting factors acting on TP receptors. RWPs are able to prevent the Ang II-induced endothelial dysfunction mostly due to their antioxidant properties.


Angiotensin II Endothelial dysfunction Polyphenols Cyclooxygenases 



This study was supported in part by VINIFLHOR (Ministry of Agriculture, France).


  1. 1.
    Luksha L, Agewall S, Kublickiene K (2009) Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 202:330–344CrossRefPubMedGoogle Scholar
  2. 2.
    Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10:1115–1126CrossRefPubMedGoogle Scholar
  3. 3.
    Vanhoutte PM (1996) Endothelial dysfunction in hypertension. J Hypertens Suppl 14:S83–S93CrossRefPubMedGoogle Scholar
  4. 4.
    Vanhoutte PM (1998) Endothelial dysfunction and vascular disease. Verh K Acad Geneeskd Belg 60:251–266PubMedGoogle Scholar
  5. 5.
    Kahonen M, Tolvanen JP, Sallinen K, Wu X, Porsti I (1998) Influence of gender on control of arterial tone in experimental hypertension. Am J Physiol 275:H15–H22PubMedGoogle Scholar
  6. 6.
    Vanhoutte PM, Feletou M, Taddei S (2005) Endothelium-dependent contractions in hypertension. Br J Pharmacol 144:449–458CrossRefPubMedGoogle Scholar
  7. 7.
    Luscher TF, Vanhoutte PM (1986) Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344–348PubMedGoogle Scholar
  8. 8.
    Zhou MS, Kosaka H, Tian RX, Abe Y, Chen QH, Yoneyama H, Yamamoto A, Zhang L (2001) L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats. J Hypertens 19:421–429CrossRefPubMedGoogle Scholar
  9. 9.
    Taylor PD, Oon BB, Thomas CR, Poston L (1994) Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 111:35–41PubMedGoogle Scholar
  10. 10.
    Tesfamariam B, Jakubowski JA, Cohen RA (1989) Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 257:H1327–H1333PubMedGoogle Scholar
  11. 11.
    Davidge ST, Zhang Y (1998) Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res 83:388–395PubMedGoogle Scholar
  12. 12.
    Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM (1995) Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76:1003–1010PubMedGoogle Scholar
  13. 13.
    Heymes C, Habib A, Yang D, Mathieu E, Marotte F, Samuel J, Boulanger CM (2000) Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol 131:804–810CrossRefPubMedGoogle Scholar
  14. 14.
    Matz RL, de Sotomayor MA, Schott C, Stoclet JC, Andriantsitohaina R (2000) Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 131:303–311CrossRefPubMedGoogle Scholar
  15. 15.
    Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM (2002) Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136:104–110CrossRefPubMedGoogle Scholar
  16. 16.
    Yang D, Feletou M, Levens N, Zhang JN, Vanhoutte PM (2003) A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension 41:143–148CrossRefPubMedGoogle Scholar
  17. 17.
    Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Qt C, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK (1997) p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45–51PubMedGoogle Scholar
  18. 18.
    Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916–1923CrossRefPubMedGoogle Scholar
  19. 19.
    Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest 95:1669–1675CrossRefPubMedGoogle Scholar
  20. 20.
    Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH, Muller B, Chataigneau T, Schini-Kerth VB (2006) Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71:794–802CrossRefPubMedGoogle Scholar
  21. 21.
    Andriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet JC, Andriantsitohaina R (1998) Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr 128:2324–2333PubMedGoogle Scholar
  22. 22.
    Carando S, Teissedre PL (1999) Catechin and procyanidin levels in French wines: contribution to dietary intake. Basic Life Sci 66:725–737PubMedGoogle Scholar
  23. 23.
    Jaimes EA, Tian RX, Pearse D, Raij L (2005) Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68:2143–2153CrossRefPubMedGoogle Scholar
  24. 24.
    Akasaki T, Ohya Y, Kuroda J, Eto K, Abe I, Sumimoto H, Iida M (2006) Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens Res 29:813–820CrossRefPubMedGoogle Scholar
  25. 25.
    Hitomi H, Kiyomoto H, Nishiyama A (2007) Angiotensin II and oxidative stress. Curr Opin Cardiol 22:311–315CrossRefPubMedGoogle Scholar
  26. 26.
    Takenaka H, Kihara Y, Iwanaga Y, Onozawa Y, Toyokuni S, Kita T (2006) Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension. J Mol Cell Cardiol 41:989–997CrossRefPubMedGoogle Scholar
  27. 27.
    Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG (1997) Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95:588–593PubMedGoogle Scholar
  28. 28.
    Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58–E65CrossRefPubMedGoogle Scholar
  29. 29.
    Wang D, Chabrashvili T, Wilcox CS (2004) Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94:1436–1442CrossRefPubMedGoogle Scholar
  30. 30.
    Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del Tacca M (2007) Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49:679–686CrossRefPubMedGoogle Scholar
  31. 31.
    Tang EH, Vanhoutte PM (2008) Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics 32:409–418PubMedGoogle Scholar
  32. 32.
    Derbyshire ZE, Halfter UM, Heimark RL, Sy TH, Vaillancourt RR (2005) Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II. Mol Cell Biochem 271:77–90CrossRefPubMedGoogle Scholar
  33. 33.
    Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB (2002) Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303:563–573CrossRefPubMedGoogle Scholar
  34. 34.
    Ohnaka K, Numaguchi K, Yamakawa T, Inagami T (2000) Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35:68–75PubMedGoogle Scholar
  35. 35.
    Alvarez Y, Perez-Giron JV, Hernanz R, Briones AM, Garcia-Redondo A, Beltran A, Alonso MJ, Salaices M (2007) Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 321:381–388CrossRefPubMedGoogle Scholar
  36. 36.
    Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S (2004) Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med 37:156–165CrossRefPubMedGoogle Scholar
  37. 37.
    Luceri C, Caderni G, Sanna A, Dolara P (2002) Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr 132:1376–1379PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Modou O. Kane
    • 1
    • 2
  • Nelly Etienne-Selloum
    • 1
  • Soccoro V. F. Madeira
    • 1
  • Mamadou Sarr
    • 1
    • 2
  • Allison Walter
    • 1
  • Stéphanie Dal-Ros
    • 1
  • Christa Schott
    • 1
  • Thierry Chataigneau
    • 1
  • Valérie B. Schini-Kerth
    • 1
    Email author
  1. 1.Département de Biophotonique et Pharmacologie, Faculté de PharmacieUniversité de Strasbourg, CNRS UMR 7213IllkirchFrance
  2. 2.Laboratoire de Physiologie Pharmaceutique, Faculté de Médecine, Pharmacie et OdontostomatologieUniversité Cheikh Anta Diop de DakarDakarSénégal

Personalised recommendations